Drug · DIN 02300575
APO-SUMATRIPTAN
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since October 14, 2009.
- Drug Identification Number (DIN)
- 02300575
- Company (DIN owner)
- Apotex Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Spray
- Route
- Nasal
- Therapeutic class (ATC)
- Sumatriptan N02CC01
- Class
- Human
- Record last updated
- June 12, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SUMATRIPTAN (SUMATRIPTAN HEMISULFATE) | 20 MG | DOSE |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 14, 2009: NOC 10662Abbreviated New Drug Submission (ANDS)
Other DINs named APO-SUMATRIPTAN
- DIN 02268388 · Marketed
- DIN 02268396 · Marketed
- DIN 02282313 · Approved
- DIN 02300567 · Approved